Section Arrow
Quote
ARCT.NASDAQ
- Arcturus Therapeutics Holdings
Quotes are at least 15-min delayed:2025/03/13 18:15 EDT
Last
 13.9
-0.355 (-2.49%)
Day High 
14.56 
Prev. Close
14.255 
1-M High
19.25 
Volume 
317.90K 
Bid
13.5
Ask
14.5
Day Low
13.57 
Open
14.15 
1-M Low
12.75 
Market Cap 
386.59M 
Currency USD 
P/E 7.2 
%Yield 3.07 
10-SMA 15.23 
20-SMA 16.09 
50-SMA 16.72 
52-W High 45 
52-W Low 12.75 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.00/-4.03
Enterprise Value
411.59M
Balance Sheet
Book Value Per Share
8.89
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
205.76M
Operating Revenue Per Share
9.69
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc0.0334-0.0234-41.20%0PE
CRVOCervoMed5.79-0.38-6.16%4.66PE
HEPAHepion Pharmaceuticals0.0378-0.011-22.54%-- 
IPAImmunoPrecise Antibodies Ltd0.405+0.0417+11.48%-- 
ONCOOnconetix Inc0.1298-0.0412-24.09%-- 
Quotes are at least 15-min delayed：2025/03/13 18:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.